EndHepCMA

EndHepCMA Coalition is a collaborative effort of organizations, providers, advocates, and consumers working to achieve the elimination of Hepatitis C in MA

[Coalition for Global Hepatitis Elimination @GlobalHep]

Do you have great photos of #hepatitis elimination efforts? Submit to our photo contest with prizes up to $1,000 USD. @Hep_Alliance @HepBFoundation @hepCoalition @hepaghana @HCVAction @INHepSU @asscatinforma @Hepatos_Aion @TaskHep @Hep_CAP @EndHepCSF @EndHepCNY @EndHepCMA

[EndHepCMA @EndHepCMA]

Congrats to the HERO team and our local #EndHepCMA member @Arthur_Kim_ID !!

[Coalition for Global Hepatitis Elimination @GlobalHep]

Just published! Results of this study on patient centered #hepC treatment models for people who inject drugs:
✔️both models resulted in high sustained virologic response
✔️ active PWID can reach high SVRs with either mDOT or patient navigation support.

https://t.co/BGcwpkZ4D9

[Empire Liver Foundation @LiverEmpire]

#HepFreeNYC!! Please join our partners @hepcure @NYSDOH_CEI @REACHProgramNYC for “#HepatitisC & #InjectionDrugUse” with Dr. Jeffrey Weiss, PhD, MS, on Tuesday 11/29/2022 4:30-5:30pm ET.

Sign up 📲https://t.co/KGf71KIwqC

[World Health Organization (WHO) @WHO]

It's #WorldHepatitisDay!

Bringing #hepatitis care closer to communities and those in need is 🗝️ to achieving a hepatitis-free future.

Here are 5⃣ things you should know about viral hepatitis �It's #WorldHepatitisDay!

Bringing #hepatitis care closer to communities and those in need is 🗝️ to achieving a hepatitis-free future.

Here are 5⃣ things you should know about viral hepatitis �It's #WorldHepatitisDay!

Bringing #hepatitis care closer to communities and those in need is 🗝️ to achieving a hepatitis-free future.

Here are 5⃣ things you should know about viral hepatitis �It's #WorldHepatitisDay!

Bringing #hepatitis care closer to communities and those in need is 🗝️ to achieving a hepatitis-free future.

Here are 5⃣ things you should know about viral hepatitis �It's #WorldHepatitisDay!

Bringing #hepatitis care closer to communities and those in need is 🗝️ to achieving a hepatitis-free future.

Here are 5⃣ things you should know about viral hepatitis �It's #WorldHepatitisDay!

Bringing #hepatitis care closer to communities and those in need is 🗝️ to achieving a hepatitis-free future.

Here are 5⃣ things you should know about viral hepatitis 👇

[Treatment Action Group (TAG) @TAGTeam_Tweets]

It's #WorldHepatitisDay! Worth the Cure is a new HepC campaign website designed to foster collaboration and provide resources to support organizing for affordable diagnostics and treatment. Check it out: https://t.co/pGZC0ToG6A

[NOhep @NO_hep]

Just 1 day to go until #WorldHepatitisDay!

✅Keep an eye out for our virtual global relay #WHDRelay

✅Download WHD campaign materials: https://t.co/8HF4TKmhvs

✅Watch the WHD Community Forum: https://t.co/jV4yddcKMD

✅Watch the PMTCT Panel Discssion: https://t.co/f8R9e5xsUu

[EndHepCMA @EndHepCMA]

Senate Approves $4 million increase! - https://t.co/gqbt2MJw8U

[EndHepCMA @EndHepCMA]

House Approves $4 million increase for HCV! - https://t.co/iEQGtXhmAD

[EndHepCMA @EndHepCMA]

HCV Treatment Training and TA - https://t.co/oFJEUGGBQv

[EndHepCMA @EndHepCMA]

Budget season is here, we need your help! - https://t.co/ZqzvvATbWX

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

New research - @PolarisObserv #HCV Collaborators - Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

https://t.co/ExDW3GmNki

#endhep #nohep @CDAFound @Homie_Razavi #LiverTwitter

[EASL Education @EASLedu]

3.26 million <18yrs were estimated to have #HCV in 2018😲

How do we care for this population especially in low & middle income countries?

Summary of Manal Hamdy El-Sayed's presenation
#EASLspecial #ViralHepatitis #HBV

@EASLnews @aelsharkawy75 @LancetGastroHep @EuropeLiver

[EndHepCMA @EndHepCMA]

Help us improve HCV care across the country! Take this 10 minute survey! @nvhr @harvardchlpi - https://t.co/yMOs0yIj0r

[EndHepCMA @EndHepCMA]

2/14 EndHepCMA Meeting Highlights - https://t.co/83qMcNBVV0

[EndHepCMA @EndHepCMA]

responses re barriers to hcv tx:
-feeling uncomfortable/judged about substance use
-prior neg healthcare experience
-concerns/misconceptions about housing or sobriety requirements
-being told they didnt need tx because of ok "levels"
-cost of medication discussed, not worth cost

[EndHepCMA @EndHepCMA]

hot of the presses! data from @EndHepCMA -directed qualitative research on barriers to #hcv treatment in MA for PWUDs (n=53):
external barriers: stigma, misconceptions around #hcv and treatment eligibility
internal: feeling unworthy of care

[EndHepCMA @EndHepCMA]

42/53 experienced societal stigma around their substance use
15 of these felt stigmatized specifically around their #hcv status

broadly negative experiences with healthcare systems, especially hospitals

[EndHepCMA @EndHepCMA]

MA has a B grade- reflecting our state's current lack of state-wide elimination plan and ongoing prior authorization barrier for MA Medicaid

[EndHepCMA @EndHepCMA]

Briefing from @HarvardCHLPI on their project, in collab w/ @NVHR1 @oneillinstitute to evaluate each state's capacity to reach Hep elimination goals #HepElimiNATION (https://t.co/BWVrfzVZ2u)

[EndHepCMA @EndHepCMA]

technical assistance and training identified as particular needs to improve #hcv screening in responding MA health centers

[EndHepCMA @EndHepCMA]

Results from MA health center survey on #hcv screening practices, in collab with @MassLeague :
80% of respondents have a designated navigator to champion HCV efforts
60% offer specific HIV and HCV screening services
Despite this overall screening rates remain low

[EndHepCMA @EndHepCMA]

Only 60% of respondents have policies and protocols in place to support the USPSTF universal HCV screening recommendation